Products for Research Use Only
RegisterLogin

BPiDI

CAT: 0804-HY-152170-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-152170-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
BPiDI is a novel selective α6β2 nicotinic receptor antagonist. bPiDI inhibits nicotine-evoked striatal dopamine (DA) release through an interaction with α6β2-containing nAChRs[1].
CAS Number
525596-64-9
UNSPSC
12352005
Target
NAChR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bpidi.html
Purity
99.65
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1=CC=C[N+](CCCCCCCCCC[N+]2=CC(C)=CC=C2)=C1.[I-].[I-]
Molecular Formula
C22H34I2N2
Molecular Weight
580.33
References & Citations
[1]Thomas E Wooters, et al. bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse. Br J Pharmacol. 2011, 163,2.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Alternative Products

CatalogName
BA6816-25bPiDI

Popular Products